ArticleFrontiers in oncology2026

Case Report: Iparomlimab and Tuvonralimab-based therapy for epithelioid malignant peritoneal mesothelioma: a three-case series.

Zhijin Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.